Health Canada approves PURE Hard Surface disinfectant

NewsGuard 100/100 Score

PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that Health Canada has approved PURE™ Hard Surface disinfectant for use in food premises, hospitals and health care facilities, domestic locations and institutional and industrial premises. PURE Hard Surface has been assigned the Drug Identification Number (DIN) 02368803.

Tom Myers, PURE's Executive Vice President, Sales and Marketing, stated, "Obtaining a DIN through Health Canada's rigorous process for approving the safety, efficacy and quality of disinfectants opens another significant market for our SDC-based PURE Hard Surface product. The approval comes at a key time as we prepare to attend the upcoming 2011 Annual Meeting of the International Association for Food Protection, which is attended by two thousand of North America's leading industry, academic and government food safety professionals."

US EPA-registered PURE Hard Surface provides an unparalleled combination of high efficacy and low toxicity with 30-second bacterial kill times and 24-hour residual protection. PURE Hard Surface completely kills resistant pathogens like MRSA and also effectively eliminates dangerous fungi and viruses including HIV, Norovirus, Influenza A, Avian Influenza and H1N1. PURE Hard Surface is EPA-registered for use on food contact surfaces and is gentle enough to be used in sensitive children's areas.

Source PURE Bioscience, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Renaissance of "food as medicine" in modern clinical trials